Outpatient Antibiotic Resistance Patterns of Escherichia coli Urinary Isolates Differ by Specialty Type.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
31 08 2022
Historique:
pubmed: 22 6 2022
medline: 9 9 2022
entrez: 21 6 2022
Statut: ppublish

Résumé

Antibiotic-resistant E. coli infections represent a major cause of morbidity and mortality and pose a challenge to antibiotic stewardship. We analyzed a large outpatient data set of E. coli urinary isolates to determine whether resistance patterns vary between types of outpatient practices. Using deidentified data from a clinical reference laboratory over 5 years and logistic regression, we examined the association of antibiotic resistance with outpatient practice type, controlling for testing year, patient sex, and patient age. The odds of antibiotic resistance were significantly higher in urology/nephrology practices for ampicillin (odds ratio [OR] 1.36; 95% CI, 1.10 to 1.69), ciprofloxacin (OR 2.29; 95% CI, 1.77 to 2.94), trimethoprim-sulfamethoxazole (OR 1.52; 95% CI, 1.18 to 1.94), and gentamicin (OR 1.72; 95% CI, 1.16 to 2.46). Odds of resistance were also higher for ciprofloxacin in oncology practices (OR 1.54; 95% CI, 1.08 to 2.15) and "all other specialties" (OR 1.33; 95% CI, 1.13 to 1.56). In contrast, specimens from obstetrics and gynecology practices had lower odds of having resistance to ampicillin (OR 0.90; 95% CI, 0.82 to 0.99) and trimethoprim-sulfa (OR 0.83; 95% CI, 0.73 to 0.93) but higher odds of having resistance to nitrofurantoin (OR 1.33; 95% CI, 1.03 to 1.70). Other findings included lower odds of having resistance to trimethoprim-sulfa in pediatric practices (OR 0.78; 95% CI, 0.64 to 0.94) and lower odds of having resistance to gentamicin in isolates from internal medicine practices (OR 0.66; 95% CI, 0.51 to 0.84) (all

Identifiants

pubmed: 35727039
doi: 10.1128/spectrum.02373-21
pmc: PMC9431218
doi:

Substances chimiques

Anti-Bacterial Agents 0
Gentamicins 0
Ciprofloxacin 5E8K9I0O4U
Ampicillin 7C782967RD
Trimethoprim, Sulfamethoxazole Drug Combination 8064-90-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0237321

Références

J Antimicrob Chemother. 2013 Mar;68(3):715-8
pubmed: 23148204
Clin Infect Dis. 2012 Sep;55(5):687-94
pubmed: 22752512
J Antimicrob Chemother. 2006 Dec;58(6):1303-6
pubmed: 17062608
Clin Infect Dis. 2016 Aug 15;63(4):443-9
pubmed: 27199462
Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
pubmed: 12113866
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):18-22
pubmed: 29324733
Obstet Gynecol. 2011 Jun;117(6):1484-1485
pubmed: 21606771
J Urol. 2005 Apr;173(4):1281-7
pubmed: 15758783
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1437-1444
pubmed: 33622432
Clin Infect Dis. 2021 Sep 15;73(6):1066-1074
pubmed: 33768228
BMC Med. 2014 Jun 11;12:96
pubmed: 24916809
J Urol. 2019 Aug;202(2):282-289
pubmed: 31042112
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Infect Chemother. 2018 Mar;50(1):67-100
pubmed: 29637759
J Antimicrob Chemother. 2017 Jan;72(1):281-289
pubmed: 27655855

Auteurs

Lauren Frisbie (L)

Department of Environmental and Occupational Health Sciences, Center for One Health Research (COHR), University of Washington School of Public Health, Seattle, Washington, USA.

Scott J Weissman (SJ)

Infectious Diseases Department, Seattle Children's Hospital, Seattle, Washington, USA.

Hema Kapoor (H)

Infectious Diseases/Immunology, Quest Diagnostics, Secaucus, New Jersey, USA.

Marisa D'Angeli (M)

Washington State Department of Healthgrid.1658.a, Shoreline, Washington, USA.

Ann Salm (A)

Infectious Diseases/Immunology, Quest Diagnostics, Secaucus, New Jersey, USA.

Jeff Radcliff (J)

Infectious Diseases/Immunology, Quest Diagnostics, Secaucus, New Jersey, USA.

Peter Rabinowitz (P)

Department of Environmental and Occupational Health Sciences, Center for One Health Research (COHR), University of Washington School of Public Health, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH